Tolerance to the glycopeptides vancomycin and teicoplanin in coagulase-negative staphylococci

Antimicrob Agents Chemother. 2007 Feb;51(2):740-3. doi: 10.1128/AAC.00719-06. Epub 2006 Nov 20.

Abstract

Tolerance to vancomycin and teicoplanin in 90 clinical isolates of coagulase-negative staphylococci (CoNS) was investigated by time-kill curve methodology. Only six strains, belonging to the Staphylococcus lugdunensis species, exhibited tolerance. The seven other S. lugdunensis strains tested displayed weak susceptibility to the bactericidal activity of glycopeptides compared to the other CoNS. These phenomena are of concern, since S. lugdunensis is recognized as one of the most pathogenic CoNS.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Coagulase / deficiency*
  • Drug Tolerance
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology
  • Staphylococcus* / drug effects
  • Staphylococcus* / enzymology
  • Teicoplanin / pharmacology*
  • Vancomycin / pharmacology*

Substances

  • Anti-Bacterial Agents
  • Coagulase
  • Teicoplanin
  • Vancomycin